Navigation Links
Neogen Launches Fully Quantitative Lateral Flow Test for Aflatoxin

LANSING, Mich., Sept. 22, 2011 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) has developed a quick and easy new test for aflatoxin, a toxin considered by many to be the most potent, naturally-occurring carcinogen. The toxin is a by-product of mold growth in a wide range of commodities, including corn. Because it is a known severe threat to human and animal health, more than 100 countries have established regulatory limits for aflatoxin in commodities intended as human food or animal feed.

Neogen's new Reveal® Q+ for Aflatoxin combines the speed and simplicity of a lateral flow screening test, like a home pregnancy test, with the fully quantitative precision of a more demanding testing method. The new test delivers precise results ranging from 2 to 150 parts per billion (ppb) of aflatoxin after only 6 minutes.

"Reveal Q+ for Aflatoxin is the easiest test available for rapid, fully quantitative test results, and uses a more environmentally friendly ethanol extraction," said Ed Bradley, Neogen's vice president for Food Safety. "This innovative technology yields more accurate and reproducible results. Coupled with Neogen's AccuScan III reader, the Reveal Q+ system objectively reads, analyzes and stores test results.

"Reveal Q+ for Aflatoxin is the first in our new line of fully quantitative lateral flow tests for mycotoxins," Bradley continued. "Tests for DON and zearalenone are in the final stages of development. The new Reveal Q+ products add to Neogen's unmatched range of simple and accurate lateral flow, microwell, immunoaffinity column mycotoxin testing options — all of which are backed by the best technical and R&D support in the industry."

Reveal Q+ for Aflatoxin offers both room temperature incubation of the test strip and storage of the test kit — eliminating the need for an incubator and refrigeration space. The test requires only minimal equipment to achieve precise results and a simple low cost ethanol extraction process. Ethanol is the preferred extract solvent of some major grain handlers.

Neogen's AccuScan® III reader provides an easy method to objectively read, store, and analyze results from Neogen's line of lateral flow tests. AccuScan provides a permanent result that can be incorporated into a company's food safety plan, such as HACCP.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

SOURCE Neogen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Webcast Alert: Neogen Corporation to Announce 1st Quarter Results
2. Neogen Reports 26% Increase in Revenues
3. Neogen Honored by Forbes; Two Brokerage Firms Initiate Coverage
4. NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10
5. Neogen Announces New Share Repurchase Program
6. Neogen Reports Best Quarter in Its 26-Year History
7. Neogens BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS
8. Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
9. Neogen Names New Senior Science Officer; Added to S&P Index
10. NeoGenomics Schedules its Q4 and Full Year 2008 Earnings Release for March 5, 2009
11. NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results
Post Your Comments:
(Date:11/25/2015)... November 25, 2015 Studies reveal ... human plaque and pave the way for more effective treatment ... cats     --> ... diagnosed health problems in cats, yet relatively little was understood ... collaborative studies have been conducted by researchers from the WALTHAM ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/24/2015)... 2015 Cepheid (NASDAQ: CPHD ) today ... following conference, and invited investors to participate via webcast. ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ... New York, NY      Tuesday, December 1, 2015 ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology:
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
Breaking Biology News(10 mins):